Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.78)
# 3,345
Out of 5,090 analysts
57
Total ratings
51.35%
Success rate
-4.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $350 → $360 | $304.49 | +18.23% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $125.08 | +16.73% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $193.96 | -5.14% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $16.40 | +21.95% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $20.92 | +291.97% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $120.50 | +105.81% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $575.34 | -41.08% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.76 | +97.37% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $2.01 | +1,243.28% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $94.28 | +17.73% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $65.49 | +119.50% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $108.51 | -48.39% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $83.43 | -11.30% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $86.19 | -11.05% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.11 | +643.19% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $91.10 | - | 1 | Dec 12, 2019 |
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $304.49
Upside: +18.23%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $125.08
Upside: +16.73%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $193.96
Upside: -5.14%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $16.40
Upside: +21.95%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $20.92
Upside: +291.97%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $120.50
Upside: +105.81%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $575.34
Upside: -41.08%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.76
Upside: +97.37%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $2.01
Upside: +1,243.28%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $94.28
Upside: +17.73%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $65.49
Upside: +119.50%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $108.51
Upside: -48.39%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $83.43
Upside: -11.30%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $86.19
Upside: -11.05%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.11
Upside: +643.19%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $91.10
Upside: -